The three source letters, complete.

FICTIONAL DEMO LETTER. No real patient. For product demonstration only. Maya Chen, MD Child and Adolescent Psychiatry 2140 Examplewood Ave, Suite 300, Sacramento, CA 95899 March 12, 2026 To the IEP Team, Lincoln Unified School District Re: A.R., DOB 6/2/2017 I am the treating psychiatrist for A.R., whom I have followed every six weeks since September 2025 for attention-deficit/hyperactivity disorder, combined presentation. She is currently prescribed methylphenidate extended-release 20 mg each morning, which her family reports she takes consistently. Her condition adversely affects her educational performance in specific, observable ways. Sustained attention deteriorates measurably under time pressure: teacher reports and my office testing agree that she completes untimed work accurately but abandons or rushes timed work after roughly fifteen minutes. Her mother reports homework sessions that stretch past two hours for thirty minutes of content. A classroom behavior plan tried in the fall improved transitions but did not change timed-test performance, which is why I am writing rather than recommending further classroom-level measures alone. I am requesting the following accommodations, each tied to the impairment above: extended time (time and a half) on all timed assessments, because her accuracy is intact when time pressure is removed; testing in a reduced-distraction environment, because her errors cluster in group settings; and scheduled movement breaks every 30 minutes, because motor restlessness precedes her off-task periods. I do not believe a scribe is indicated, and I am not asking the district to alter curriculum content or grading standards. I expect these supports to be needed for at least the current and next academic year, with reassessment at that point. These accommodations are required for A.R. to demonstrate what she has actually learned. I am available to the team for questions through my office. Sincerely, Maya Chen, MD CA License A123456 (fictional)

FICTIONAL DEMO LETTER. No real patient. For product demonstration only. Maya Chen, MD Child and Adolescent Psychiatry 2140 Examplewood Ave, Suite 300, Sacramento, CA 95899 April 3, 2026 To Whom It May Concern, This patient was under my care and unable to attend work from March 30 to April 3, 2026. They may return to full duties on April 6, 2026 without restriction. Please contact my office if verification is needed. Sincerely, Maya Chen, MD CA License A123456 (fictional)

FICTIONAL DEMO LETTER. No real patient. For product demonstration only. Maya Chen, MD Child and Adolescent Psychiatry 2140 Examplewood Ave, Suite 300, Sacramento, CA 95899 May 20, 2026 Blue Shield of California, Pharmacy Appeals Re: J.T., Member ID XZ0000000 (fictional), denial of lisdexamfetamine I am appealing the step-therapy denial dated May 14, 2026 under plan policy section 7.4.2. Per the plan's own criteria, coverage is appropriate after failure of two preferred agents at adequate dose and duration. J.T. completed methylphenidate ER titrated to 54 mg for 10 weeks with inadequate response, then mixed amphetamine salts ER 25 mg for 8 weeks discontinued for intolerable appetite suppression and a 4.1 kg weight loss. Both trials are documented in the enclosed records in the order the plan requests. Continued treatment with lisdexamfetamine is medically necessary; it is the only agent that has produced functional improvement at school and home. I request reversal of the denial and am available for peer-to-peer review Tuesdays and Thursdays 12 to 1 pm. Sincerely, Maya Chen, MD CA License A123456 (fictional)